Publications

  1. Barton DL, Thanarajasingam G, Sloan JA, Diekmann B, Fuloria J, Kottschade LA, Lyss AP, Jaslowski AJ, Mazurczak MA, Blair SC, Terstriep S, Loprinzi CL. Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance). Cancer. 2014 Jul 09.
    View PubMed
  2. Barton D. Journey to Oz in search of a remedy for fatigue. Cancer J. 2014 Jan-Feb; 20(1):15-7.
    View PubMed
  3. Vincent A, Whipple MO, Oh TH, Guderian JA, Barton DL, Luedtke CA. Early experience with a brief, multimodal, multidisciplinary treatment program for fibromyalgia. Pain Manag Nurs. 2013 Dec; 14(4):228-35. Epub 2011 Jul 2
    View PubMed
  4. Lavoie Smith EM, Barton DL, Qin R, Steen PD, Aaronson NK, Loprinzi CL. Assessing patient-reported peripheral neuropathy: the reliability and validity of the european organization for research and treatment of cancer qlq-cipn20 questionnaire. Qual Life Res. 2013 Dec; 22(10):2787-99.
  5. Pachman DR, Loprinzi CL, Novotny PJ, Satele DV, Linquist BM, Wolf S, Barton DL. Sternal skin conductance: a reasonable surrogate for hot flash measurement? Menopause. 2013 Nov; 20(11):1164-8.
    View PubMed
  6. Barton DL, Liu H, Dakhil SR, Linquist B, Sloan JA, Nichols CR, McGinn TW, Stella PJ, Seeger GR, Sood A, Loprinzi CL. Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst. 2013 Aug 21; 105(16):1230-8. Epub 2013 Jul 13.
    View PubMed
  7. Vincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH, Barton DL, St Sauver J. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res (Hoboken). 2013 May; 65(5):786-92.
    View PubMed
  8. Barton DL, Burger K, Novotny PJ, Fitch TR, Kohli S, Soori G, Wilwerding MB, Sloan JA, Kottschade LA, Rowland KM Jr, Dakhil SR, Nikcevich DA, Loprinzi CL. The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9. Support Care Cancer. 2013 Apr; 21(4):1185-92. Epub 2012 Nov 13.
    View PubMed
  9. Sood R, Sood A, Wolf SL, Linquist BM, Liu H, Sloan JA, Satele DV, Loprinzi CL, Barton DL. Paced breathing compared with usual breathing for hot flashes. Menopause. 2013 Feb; 20(2):179-84.
    View PubMed
  10. Ness S, Kokal J, Fee-Schroeder K, Novotny P, Satele D, Barton D. Concerns across the survivorship trajectory: results from a survey of cancer survivors. Oncol Nurs Forum. 2013 Jan; 40(1):35-42.
    View PubMed
  11. Pachman DR, Barton DL, Swetz KM, Loprinzi CL. Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol. 2012 Oct 20; 30(30):3687-96. Epub 2012 Sep 24.
    View PubMed
  12. Kadakia KC, Barton DL, Loprinzi CL, Sloan JA, Otley CC, Diekmann BB, Novotny PJ, Alberts SR, Limburg PJ, Pittelkow MR. Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251). Cancer. 2012 Apr 15; 118(8):2128-37. Epub 2011 Aug 31.
    View PubMed
  13. Wolf SL, Barton DL, Qin R, Wos EJ, Sloan JA, Liu H, Aaronson NK, Satele DV, Mattar BI, Green NB, Loprinzi CL. The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA. Support Care Cancer. 2012 Mar; 20(3):625-32. Epub 2011 Apr 12.
    View PubMed
  14. Barton DL, Pachman DR. Clinical trials in integrative therapies. Semin Oncol Nurs. 2012 Feb; 28(1):10-28.
    View PubMed
  15. Pachman DR, Barton DL, Clayton AC, McGovern RM, Jefferies JA, Novotny PJ, Sloan JA, Loprinzi CL, Gostout BS. Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia. Am J Obstet Gynecol. 2012 Jan; 206(1):42.e1-7. Epub 2011 Jul 13.
    View PubMed
  16. Pruthi S, Qin R, Terstreip SA, Liu H, Loprinzi CL, Shah TR, Tucker KF, Dakhil SR, Bury MJ, Carolla RL, Steen PD, Vuky J, Barton DL. A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7. Menopause. 2012 Jan; 19(1):48-53.
    View PubMed
  17. Pachman DR, Barton DL, Watson JC, Loprinzi CL. Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clin Pharmacol Ther. 2011 Sep; 90(3):377-87. Epub 2011 Aug 03.
    View PubMed
  18. Pachman DR, Barton D, Carns PE, Novotny PJ, Wolf S, Linquist B, Kohli S, Smith DR, Loprinzi CL. Pilot evaluation of a stellate ganglion block for the treatment of hot flashes. Support Care Cancer. 2011 Jul; 19(7):941-7. Epub 2010 May 23.
    View PubMed
  19. Barton DL, Wos EJ, Qin R, Mattar BI, Green NB, Lanier KS, Bearden JD 3rd, Kugler JW, Hoff KL, Reddy PS, Rowland KM Jr, Riepl M, Christensen B, Loprinzi CL. A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer. 2011 Jun; 19(6):833-41. Epub 2010 May 25.
    View PubMed
  20. Barton D. Oral agents in cancer treatment: the context for adherence. Semin Oncol Nurs. 2011 May; 27(2):104-15.
    View PubMed
  21. Barton D. Ginseng Oncology Nurse Edition. 2011 Apr; 25(4):42-45.
  22. Barton DL, Atherton PJ, Bauer BA, Moore DF Jr, Mattar BI, Lavasseur BI, Rowland KM Jr, Zon RT, Lelindqwister NA, Nagargoje GG, Morgenthaler TI, Sloan JA, Loprinzi CL. The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5). J Support Oncol. 2011 Jan-Feb; 9(1):24-31.
    View PubMed
  23. Moraska AR, Sood A, Dakhil SR, Sloan JA, Barton D, Atherton PJ, Suh JJ, Griffin PC, Johnson DB, Ali A, Silberstein PT, Duane SF, Loprinzi CL. Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. J Clin Oncol. 2010 Aug 10; 28(23):3673-9. Epub 2010 Jul 12.
    View PubMed
  24. Barton DL, LaVasseur BI, Sloan JA, Stawis AN, Flynn KA, Dyar M, Johnson DB, Atherton PJ, Diekmann B, Loprinzi CL. Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9. J Clin Oncol. 2010 Jul 10; 28(20):3278-83. Epub 2010 May 24.
    View PubMed
  25. Moraska AR, Atherton PJ, Szydlo DW, Barton DL, Stella PJ, Rowland KM Jr, Schaefer PL, Krook J, Bearden JD, Loprinzi CL. Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB. J Support Oncol. 2010 May-Jun; 8(3):128-32.
    View PubMed
  26. Barton DL, Soori GS, Bauer BA, Sloan JA, Johnson PA, Figueras C, Duane S, Mattar B, Liu H, Atherton PJ, Christensen B, Loprinzi CL. Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer. 2010 Feb; 18(2):179-87. Epub 2009 May 06.
    View PubMed
  27. Barton D, Bauer-Wu S. Vitamin D. Oncology (Williston Park). 2009 Oct; 23(11 Suppl Nurse Ed):50-3.
    View PubMed
  28. Barton D, Bauer-Wu S. The emerging discipline of integrative oncology. Oncology (Williston Park). 2009 Oct; 23(11 Suppl Nurse Ed):46-9.
    View PubMed
  29. Loprinzi CL, Sloan J, Stearns V, Slack R, Iyengar M, Diekmann B, Kimmick G, Lovato J, Gordon P, Pandya K, Guttuso T Jr, Barton D, Novotny P. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol. 2009 Jun 10; 27(17):2831-7. Epub 2009 Mar 30.
    View PubMed
  30. Bardia A, Novotny P, Sloan J, Barton D, Loprinzi C. Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis. Menopause. 2009 May-Jun; 16(3):477-83.
    View PubMed
  31. Loprinzi CL, Dueck AC, Khoyratty BS, Barton DL, Jafar S, Rowland KM Jr, Atherton PJ, Marsa GW, Knutson WH, Bearden JD 3rd, Kottschade L, Fitch TR. A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB). Ann Oncol. 2009 Mar; 20(3):542-9. Epub 2009 Jan 06.
    View PubMed
  32. Loprinzi CL, Barton DL, Sloan JA, Novotny PJ, Wolf S. Newer antidepressants for hot flashes--should their efficacy still be up for debate? Menopause. 2009 Jan-Feb; 16(1):184-7.
    View PubMed
  33. Loprinzi CL, Barton DL. Drs. Loprinzi and Barton respond. J Support Oncol. 2009; 7(6):253-4.
    View PubMed
  34. Ponto JA, Barton D. Husbands' perspective of living with wives' ovarian cancer. Psychooncology. 2008 Dec; 17(12):1225-31.
    View PubMed
  35. Loprinzi CL, Wolf SL, Barton DL, Laack NN. Symptom management in premenopausal patients with breast cancer. Lancet Oncol. 2008 Oct; 9(10):993-1001.
    View PubMed
  36. Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer. 2008 Jul; 44(11):1507-15. Epub 2008 Jun 18.
    View PubMed
  37. Loprinzi CL, Barton DL, Sloan JA, Novotny PJ, Dakhil SR, Verdirame JD, Knutson WH, Kelaghan J, Christensen B. Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a 20-year experience. Menopause. 2008 Jul-Aug; 15(4 Pt 1):655-60.
    View PubMed
  38. Barton DL. Menopausal symptoms following tamoxifen treatment for breast cancer. Oncology (Williston Park). 2008 Apr; 22(4 Suppl Nurse Ed):46-8.
    View PubMed
  39. Thompson S, Bardia A, Tan A, Barton DL, Kottschade L, Sloan JA, Christensen B, Smith D, Loprinzi CL. Levetiracetam for the treatment of hot flashes: a phase II study. Support Care Cancer. 2008 Jan; 16(1):75-82. Epub 2007 Jun 28.
    View PubMed
  40. Palmieri FM, Barton DL. Challenges of oral medications in patients with advanced breast cancer. Semin Oncol Nurs. 2007 Nov; 23(4 Suppl 2):S17-22.
    View PubMed
  41. Barton DL, Loprinzi CL, Atherton P, Raymond J, Shanafelt T, Hines S, Palmieri F, Rummans T, Adjei AA, Sloan J. Phase II Evaluation of Desipramine for the Treatment of Hot Flashes. Support Cancer Ther. 2007 Sep 1; 4(4):219-24.
    View PubMed
  42. Pruthi S, Thompson SL, Novotny PJ, Barton DL, Kottschade LA, Tan AD, Sloan JA, Loprinzi CL. Pilot evaluation of flaxseed for the management of hot flashes. J Soc Integr Oncol. 2007 Summer; 5(3):106-12.
    View PubMed
  43. Barton DL, Wender DB, Sloan JA, Dalton RJ, Balcueva EP, Atherton PJ, Bernath AM Jr, DeKrey WL, Larson T, Bearden JD 3rd, Carpenter PC, Loprinzi CL. Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3. J Natl Cancer Inst. 2007 May 2; 99(9):672-9.
    View PubMed
  44. Loprinzi CL, Barton DL, Jatoi A, Sloan J, Martenson J, Steensma D, Rao R, Novotny P, Sood A, Grothey A, Minasian L, Windschitl H. Symptom control trials: a 20-year experience. J Support Oncol. 2007 Mar; 5(3):119-25, 128.
    View PubMed
  45. Sood A, Barton DL, Bauer BA, Loprinzi CL. A critical review of complementary therapies for cancer-related fatigue. Integr Cancer Ther. 2007 Mar; 6(1):8-13.
    View PubMed
  46. Loprinzi CL, Kugler JW, Barton DL, Dueck AC, Tschetter LK, Nelimark RA, Balcueva EP, Burger KN, Novotny PJ, Carlson MD, Duane SF, Corso SW, Johnson DB, Jaslowski AJ. Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5. J Clin Oncol. 2007 Jan 20; 25(3):308-12. Epub 2006 Dec 04.
    View PubMed
  47. Vincent A, Barton DL, Mandrekar JN, Cha SS, Zais T, Wahner-Roedler DL, Keppler MA, Kreitzer MJ, Loprinzi C. Acupuncture for hot flashes: a randomized, sham-controlled clinical study. Menopause. 2007 Jan-Feb; 14(1):45-52.
    View PubMed
  48. Collins M, Barton DL. The prevalence, assessment and management of hot flashes in women without hormones A Journal of Practical Medicine. 2007; 50(2):23-9.
  49. Bardia A, Barton DL, Prokop LJ, Bauer BA, Moynihan TJ. Efficacy of complementary and alternative medicine therapies in relieving cancer pain: a systematic review. J Clin Oncol. 2006 Dec 1; 24(34):5457-64.
    View PubMed
  50. Barton DL, Loprinzi C, Jatoi A, Vincent A, Limburg P, Bauer B, Sood A, Good M, Bearden JD 4th, Kelaghan J, Sloan J. Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience. J Soc Integr Oncol. 2006 Fall; 4(4):143-52.
    View PubMed
  51. Bardia A, Thompson S, Atherton PJ, Barton DL, Sloan JA, Kottschade LA, Christensen B, Collins M, Loprinzi CL. Pilot evaluation of aprepitant for the treatment of hot flashes. Support Cancer Ther. 2006 Jul 1; 3(4):240-6.
    View PubMed
  52. Pockaj BA, Gallagher JG, Loprinzi CL, Stella PJ, Barton DL, Sloan JA, Lavasseur BI, Rao RM, Fitch TR, Rowland KM, Novotny PJ, Flynn PJ, Richelson E, Fauq AH. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol. 2006 Jun 20; 24(18):2836-41.
    View PubMed
  53. Perez DG, Loprinzi CL, Sloan J, Novotny P, Barton D, Carpenter L, Smith D, Christensen B, Rummans T. Pilot evaluation of bupropion for the treatment of hot flashes. J Palliat Med. 2006 Jun; 9(3):631-7.
    View PubMed
  54. Loprinzi CL, Levitt R, Barton D, Sloan JA, Dakhil SR, Nikcevich DA, Bearden JD 3rd, Mailliard JA, Tschetter LK, Fitch TR, Kugler JW. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7. J Clin Oncol. 2006 Mar 20; 24(9):1409-14. Epub 2006 Feb 27.
    View PubMed
  55. Barton DL, Loprinzi C, Atherton PJ, Kottschade L, Collins M, Carpenter P, Adjei A, Rummans TA, Shanafelt T, Christensen B, Sloan J. Dehydroepiandrosterone for the treatment of hot flashes: a pilot study. Support Cancer Ther. 2006 Jan 1; 3(2):91-7.
    View PubMed
  56. Sood A, Barton DL, Loprinzi CL. Use of methylphenidate in patients with cancer. Am J Hosp Palliat Care. 2006 Jan-Feb; 23(1):35-40.
    View PubMed
  57. Loprinzi CL, Stearns V, Barton D. Centrally active nonhormonal hot flash therapies. Am J Med. 2005 Dec 19; 118 Suppl 12B:118-23.
    View PubMed
  58. Loprinzi CL, Flynn PJ, Carpenter LA, Atherton P, Barton DL, Shanafelt TD, Rummans TA, Sloan JA, Adjei AA, Mincey BA, Fitch TR, Collins M. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine. J Palliat Med. 2005 Oct; 8(5):924-30.
    View PubMed
  59. Loprinzi CL, Levitt R, Barton DL, Sloan JA, Atherton PJ, Smith DJ, Dakhil SR, Moore DF Jr, Krook JE, Rowland KM Jr, Mazurczak MA, Berg AR, Kim GP, North Central Cancer Treatment Group. Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial. Cancer. 2005 Jul 1; 104(1):176-82.
    View PubMed
  60. Molina JR, Barton DL, Loprinzi CL. Chemotherapy-induced ovarian failure: manifestations and management. Drug Saf. 2005; 28(5):401-16.
    View PubMed
  61. Loprinzi CL, Barton DL, Carpenter LA, Sloan JA, Novotny PJ, Gettman MT, Christensen BJ. Pilot evaluation of paroxetine for treating hot flashes in men. Mayo Clin Proc. 2004 Oct; 79(10):1247-51.
    View PubMed
  62. Barton D, Wilwerding M, Carpenter L, Loprinzi C. Libido as part of sexuality in female cancer survivors. Oncol Nurs Forum. 2004 May; 31(3):599-609.
    View PubMed
  63. Perez DG, Loprinzi CL, Barton DL, Pockaj BA, Sloan J, Novotny PJ, Christensen BJ. Pilot evaluation of mirtazapine for the treatment of hot flashes. J Support Oncol. 2004 Jan-Feb; 2(1):50-6.
    View PubMed
  64. Barton D, Loprinzi C. Making sense of the evidence regarding nonhormonal treatments for hot flashes. Clin J Oncol Nurs. 2004; 8(1):39-42.
    View PubMed
  65. Pockaj BA, Loprinzi CL, Sloan JA, Novotny PJ, Barton DL, Hagenmaier A, Zhang H, Lambert GH, Reeser KA, Wisbey JA. Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Invest. 2004; 22(4):515-21.
    View PubMed
  66. Barton DL, Loprinzi CL, Novotny P, Shanafelt T, Sloan J, Wahner-Roedler D, Rummans TA, Christensen B, Dakhill SR, Martin LS. Pilot evaluation of citalopram for the relief of hot flashes. J Support Oncol. 2003 May-Jun; 1(1):47-51.
    View PubMed
  67. Barton D, Loprinzi C. Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: the art of the possible. Clinical Breast Cancer. 2002 Dec; 3 Suppl 3:S121-7.
    View PubMed
  68. Barton D, Loprinzi C, Quella S, Sloan J, Pruthi S, Novotny P. Depomedroxyprogesterone acetate for hot flashes. J Pain Symptom Manage. 2002 Dec; 24(6):603-7.
    View PubMed
  69. Loprinzi L, Barton DL, Sloan JA, Zahasky KM, Smith DA, Pruthi S, Novotny PJ, Perez EA, Christensen BJ. Pilot evaluation of gabapentin for treating hot flashes. Mayo Clin Proc. 2002 Nov; 77(11):1159-63.
    View PubMed
  70. Shanafelt TD, Barton DL, Adjei AA, Loprinzi CL. Pathophysiology and treatment of hot flashes. Mayo Clin Proc. 2002 Nov; 77(11):1207-18.
    View PubMed
  71. Loprinzi CL, Barton DL, Rhodes DJ, Wahner-Roedler DL. Newer antidepressants for hot flashes. Patient Care. 2002 Jul; 36(9):45-6, 49-51.
    View PubMed
  72. Barton DL, Loprinzi C, Gostout B. Current management of menopausal symptoms in cancer patients. Oncology (Williston Park) 2002 Jan; 16(1):67-72, 74; discussion 75-6, 79-80.
    View PubMed
  73. Barton D, La Vasseur B, Loprinzi C, Novotny P, Wilwerding MB, Sloan J. Venlafaxine for the control of hot flashes: results of a longitudinal continuation study. Oncol Nurs Forum. 2002 Jan-Feb; 29(1):33-40.
    View PubMed
  74. Barton DL, Loprinzi CL, Ko MG. Managing hot flashes: The truth about the alternatives to traditional hormone replacement therapy. Menopause Manage. 2002;11(3):15-19.
  75. Rawl S, Champion V, Emsley C, Williams S, Barton D, Given B, Given C, Kozachik S. Advanced practice nursing interventions to improve quality of life for newly diagnosed cancer patients. Oncology Nursing Forum. 2002; 29(6):967-975.
    View PubMed
  76. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot flash studies. J Clin Oncol. 2001 Dec 1; 19(23):4280-90.
    View PubMed
  77. Loprinzi CL, Barton DL, Rhodes DJ, Wahner-Roedler DL. Newer antidepressants for hot flashes. Contemp Ob Gyn. 2001 Nov; 46(11):61-2, 64, 67 passim.
  78. Loprinzi CL, Barton DL, Rhodes D. Management of hot flashes in breast-cancer survivors. Lancet Oncol. 2001 Apr; 2(4):199-204.
    View PubMed
  79. Barton D, Loprinzi C, Wahner-Roedler D. Hot flashes: aetiology and management. Drugs Aging. 2001; 18(8):597-606.
    View PubMed
  80. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, LaVasseur BI, Barton DL, Novotny PJ, Dakhil SR, Rodger K, Rummans TA, Christensen BJ. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet. 2000 Dec 16; 356(9247):2059-63.
    View PubMed
  81. Quella SK, Loprinzi CL, Barton DL, Knost JA, Sloan JA, LaVasseur BI, Swan D, Krupp KR, Miller KD, Novotny PJ. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J Clin Oncol. 2000 Mar; 18(5):1068-74.
    View PubMed
  82. Sloan JA, Loprinzi CL, Novotny PJ, Okuno S, Nair S, Barton DL. Sex differences in fluorouracil-induced stomatitis. J Clin Oncol. 2000 Jan; 18(2):412-20.
    View PubMed
  83. Finck G, Barton DL, Loprinzi CL, Quella SK, Sloan JA. Definitions of hot flashes in breast cancer survivors. J Pain Symptom Manage. 1998 Nov; 16(5):327-33.
    View PubMed
  84. Barton DL, Loprinzi CL, Quella SK, Sloan JA, Veeder MH, Egner JR, Fidler P, Stella PJ, Swan DK, Vaught NL, Novotny P. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol. 1998 Feb; 16(2):495-500.
    View PubMed
  85. Wilwerding MB, Loprinzi CL, Mailliard JA, O'Fallon JR, Miser AW, Vanhaelst C, Barton DL, Foley JF, Athmann LM. A randomized crossover evaluation of methyphenidate in cancer patients receiving strong narcotics. Support Care Cancer. 1995 Mar; 3:135-8.
    View PubMed
  86. Burgener S, Jirovec M, Murrell L, Barton D. Caregiver and environmental variables related to difficult behaviors in institutionalized, demented elderly persons. Journal of Gerontology, PsychSciences. 1992; 47:242-249.
  87. Burgener S, Barton D. Nursing care of cognitively impaired institutionalized elderly. Journal of Gerontological Nursing. 1991; 12(2):1-7.